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Abstract 
Background: Phospholipase A1 is an enzyme that hydrolyzes phospholipids at the sn‑1 position. It has potential 
applications across diverse fields including food, pharmaceutical, and biofuel industries. Although there has been 
increasing interest in the use of phospholipase A1 for degumming of plant oils during biodiesel production, produc‑
tion of recombinant phospholipase A1 has been hampered by low efficiency of gene expression and its toxicity to the 
host cell.
Results: While expression of phospholipase A1 in Escherichia coli resulted in extremely low productivity associated 
with inhibition of transformed cell growth, drastically higher production of functional phospholipase A1 was achieved 
in a cell‑free protein synthesis system where enzyme expression is decoupled from cell physiology. Compared with 
expression in E. coli, cell‑free synthesis resulted in an over 1000‑fold higher titer of functional phospholipase A1. Cell‑
free produced phospholipase A1 was also used for successfully degumming crude plant oil.
Conclusions: We demonstrate successful production of Serratia sp. phospholipase A1 in a cell‑free protein synthesis 
system. Including the phospholipase A1 investigated in this study, many industrial enzymes can interfere with the 
regular physiology of cells, making cellular production of them problematic. With the experimental results presented 
herewith, we believe that cell‑free protein synthesis will provide a viable option for rapid production of important 
industrial biocatalysts.
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Background
Increasing demand for sustainable energy has accelerated 
research and development in biodiesel as well as other 
sectors of the biofuel industry [1]. Crude oils extracted 
from plants contain a variety of non-triglyceride compo-
nents, which need to be removed before the oils can be 
used as feedstock for biodiesel production.
Degumming is a common practice for the removal of 
phospholipids before vegetable oils are fed into the bio-
diesel production process [2]. Phospholipid removal is 
of particular importance during enzymatic biodiesel 
production because phospholipids substantially inhibit 
enzymatic transesterification reactions and decrease the 
efficiency of biodiesel separation [3, 4]. While hydrat-
able phospholipids can be readily removed by the simple 
water degumming process, removal of nonhydratable 
phospholipids typically requires a chemical refining pro-
cess that usually consists of sequential acid and alkali 
treatment steps [5]. The chemical degumming process, 
however, produces large amounts of soapstock, which 
causes significant loss of oil during its separation. The 
use of caustic chemicals also has negative impacts on the 
environment. In this respect, phospholipase A1 (PLA1)-
mediated enzymatic degumming to convert nonhydrat-
able phospholipids into hydrophilic lysophospholipids is 
considered to be a simpler, more efficient and environ-
ment-friendly alternative to the chemical processes [6, 
7]. Although there are a few commercially available PLA1 
sources, relatively little effort has been directed toward 
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the development of bacterial phospholipases for indus-
trial enzymatic degumming. Because plant oils differ sub-
stantially in their composition and phospholipid content, 
it is highly desirable to have a technological platform to 
produce and characterize phospholipases from diverse 
sources.
Unlike the conventional cell-based gene expression 
methods, cell-free protein synthesis uses protein syn-
thesis machinery in open environments and thus can 
produce proteins by direct addition of template DNA. 
Therefore, it offers a much faster and more flexible route 
to protein production [8]. In addition, cell-free protein 
synthesis does not require the maintenance of cell viabil-
ity and integrity of cellular membranes. These unique 
features make cell-free protein synthesis a potentially 
ideal platform to produce recombinant enzymes that 
otherwise would interfere with the normal physiology of 
host cells.
In this study, the technique of cell-free protein synthe-
sis was applied to the expression of functional phospho-
lipase A1 (PLA1) from Serrartia sp. While significant 
amounts of recombinant PLA1 were not obtained from 
liter-scale cultures of Escherichia coli (E. coli) due to 
substantial inhibition of cell growth and protein biosyn-
thesis, cell-free synthesis reactions at microliter scales 
produced functional PLA1 in amounts sufficient for sub-
sequent analyses. PLA1 synthesized in the cell-free sys-
tem was confirmed to be highly functional and successful 
at degumming crude sesame oil. Furthermore, the cell-
free synthesis reaction was proven to be readily scalable, 
showing constant volumetric productivity when scaled-
up from 150 µL to 500 mL. As expected, when our phos-
pholipase A1 was utilized to degum crude oil, the cloudy 
oil was converted to clear. These results demonstrate that 
cell-free synthesis provides a versatile platform for the 
production of functional phospholipases, and it can be 
extended to the production of other industrially impor-
tant enzymes from analytical to preparative scales.
Methods
Chemicals and enzymes
Sesame crude oil was purchased from the market (Dae-
jeon, Korea). Luria-Bertani (LB) medium and ampicil-
lin were purchased from Duchefa Biochemie (Haarlem, 
The Netherlands). Ni-NTA agarose resin was from 
Qiagen (Hilden, Germany). ATP, GTP, UTP, CTP, and 
creatine kinase were purchased from Roche Applied Sci-
ence (Indianapolis, IN). Creatine phosphate was a kind 
gift from Bioneer Co. (Daejeon, Korea). L-[U-14C] leu-
cine was from Perkin Elmer (Waltham, MA). All other 
chemical reagents were obtained from Sigma-Aldrich (St 
Louis, MI) and used without further purification. The S12 
extract prepared from the E. coli strain BL21Star (DE3) 
(Invitrogen, Carlsbad, CA) was used as a source of pro-
tein synthesis machinery as described previously [9].
Expression of Serratia PLA1 in E. coli
The PLA1 gene was PCR-amplified from genomic DNA 
of Serratia sp. MK1 [10] and cloned into the pET21a and 
the pSTV28 plasmids. The resulting plasmids (pET21a 
Serr PLA1 and pSTV28 Serr PLA1) was transformed into 
the E. coli strain BL21Star (DE3). After overnight incuba-
tion of the seed culture in 5 mL of LB, 4 mL each of the 
resulting bacterial culture was transferred into 400 mL of 
LB medium (50 µg/mL of ampicillin or 25 µg/mL of chlo-
ramphenicol was used as the antibiotic for each transfor-
mant) in two 3 L flasks and grown at 37 °C with vigorous 
shaking. Expression of PLA1 was induced with 0.6  mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) when the 
OD600 of culture broth reached 0.6. Samples were taken 
throughout the culture period for the assay of expressed 
enzyme after disruption of the cells by sonication.
Cell‑free synthesis of Serratia PLA1
The plasmid pET21a Serr PLA1 used for E. coli-based 
expression of Serratia PLA1 was also used as the tem-
plate for the cell-free protein synthesis reactions. The 
standard reaction mixture for cell-free synthesis consists 
of the following components in 150 µL: 57 mM HEPES–
KOH (pH 7.5); 1.2 mM ATP; 0.85 mM each of GTP, UTP, 
and CTP; 80 mM ammonium acetate; 34 µg/mL 1-5-for-
myl-5,6,7,8-tetrahydrofolic acid (folinic acid); 1.0  mM 
each of the 20 amino acids; 2  % PEG (8000); 3.2  U/mL 
of creatine kinase; 67 mM creatine phosphate; 0.01 mM 
L-[U-14C] leucine (11.1 GBq/mmol); 27 % (v/v) of the S12 
extract; and 13.0 μg/mL of plasmid. After incubation of 
the reaction mixture at 37 °C for 3 h, cell-free synthesized 
protein was quantified by measuring trichloroacetic acid 
(TCA)-insoluble radioactivity using a Tri-Carb 2810TR 
liquid scintillation counter (PerkinElmer, Waltham, MA), 
as described previously [8, 11]. Cell-free synthesized 
proteins were also analyzed on 12  % SDS-PAGE gels. 
Enzymatic activity of the PLA1 protein produced dur-
ing cell-free synthesis reactions was determined using 
EnzChek® Phospholipase A1 Assay Kit (Invitrogen, Carls-
bad, CA) following the manufacturer’s protocols.
Purification of recombinant PLA1
For purification of the PLA1 expressed in E. coli, cells 
were harvested from 1 L of culture broth at 16 h after the 
addition of IPTG, washed with 500 mL of phosphate buff-
ered saline (PBS) and resuspended in 20  mL of 50  mM 
sodium phosphate buffer containing 300  mM NaCl and 
10  mM imidazole (pH 8.0). The cells were disrupted by 
sonication on ice. After removing cell debris by centrifu-
gation (10,000 RCF, 15 min), the supernatant was mixed 
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with a 1 mL suspension of Ni-NTA agarose resin. After 
incubation for 30 min with gentle agitation, the Ni-NTA 
agarose resin was washed thrice with 100  mL of buffer 
A (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 
pH 8.0). Subsequent to the final wash, bound proteins 
were eluted with 5  mL of buffer E (50  mM  NaH2PO4, 
300 mM NaCl, 250 mM Imidazole, pH 8.0) and dialyzed 
against 1 L of 10 mM sodium phosphate buffer (pH 7.4) 
at twice. For the purification of cell-free synthesized 
PLA1, 3  mL of a completed cell-free synthesis reaction 
was centrifuged at 10,000 RCF for 15 min and the super-
natant was mixed with 1 mL suspension of Ni-NTA aga-
rose resin. After incubation for 30  min, the beads were 
washed thrice with 2 mL of buffer A. Subsequent to the 
final wash, bound protein was eluted with 5 mL of buffer 
E and twice dialyzed against 1 L of 10 mM sodium phos-
phate buffer (pH 7.4).
Degumming of crude plant oils using cell‑free synthesized 
PLA1
Ten  mL of crude sesame oil was heated to 60  °C in a 
water bath for 1  h and cooled down to 40  °C. Vary-
ing amounts of purified PLA1 was diluted in 0.5  mL of 
deionized water and added to the sesame oil. The PLA1 
enzyme was dispersed in oil/water emulsion by vortex-
ing (3000 rpm, 1 min) the mixture. The degumming reac-
tion was conducted by placing the tube in an incubating 
shaker set at 300  rpm and 40  °C. After 12  h of incuba-
tion, the degumming reaction was stopped by heating the 
reaction mixture to 90 °C for 10 min. 0.4 mL of samples 
were taken and analyzed using a Rxi®-5 Sil MS column 
(Restek, Bellefonte, PA) in a GC7890A gas chromatog-
raphy analyzer (Agilent Technologies, Santa Clara, CA) 
connected to a 5975c mass selective detector (MSD). The 
oven was held at 80  °C for 2  min, ramped to 140  °C at 
a rate of 10  °C/min, to 240  °C at a rate of 4  °C/min, to 
300 °C at a rate of 10 °C/min, and then held at 300 °C for 
20 min. Helium was used as the carrier gas at a constant 
flow rate of 1 mL/min through the column. As an indi-
cator of degumming products, concentration of linoleic 
acid was measured using dodecanoic acid as an internal 
standard [12].
Results and discussion
E. coli‑based expression of recombinant Serratia PLA1
We previously reported very low expression levels of 
recombinant Serratia PLA1 in E. coli [13–16]. When 
the PLA1 gene was expressed under the control of 
the weak lac promoter on a low copy number plas-
mid (pSTV28), approximately 100  µg of purified PLA1 
enzyme was obtained from a 100  mL culture of trans-
formed E. coli. It should be noted that the expression 
level of PLA1 was even lower when the same gene was 
moved to an expression vector containing a strong pro-
moter. For example, when cloned in the pQE70 plasmid 
under the T5 promoter, less than 30 µg of purified PLA1 
was obtained from a 100 mL culture. Although not dis-
cussed in the previous reports, this appears to be due 
to the toxicity of the enzyme to E. coli. Because the T7 
promoter used in this study is stronger than the T5 pro-
moter [17–19], we expected that the induction of PLA1 
expression would further decrease the yield of PLA1. 
Indeed, during the cultivation of E. coli transformed with 
the plasmid pET21a Serr PLA1, we found significant 
growth inhibition after induction with IPTG. A decrease 
in the growth rate of approximately 25 % was observed in 
induced E. coli as compared to a control culture without 
IPTG induction (Fig. 1a). Although time-course analysis 
of PLA1 activity indicated accumulation of functional 
PLA1 after IPTG induction (Fig. 1b), the expression level 
was too low to be confirmed by SDS-PAGE and immu-
noblot analysis (data not shown). We presumed that the 
onset of PLA1 expression from the strong T7 promoter 
caused significant damage to the cells and decreased cel-
lular production of proteins. This presumption was con-
firmed by measuring the amounts of total cellular protein 
in the E. coli with or without IPTG induction. As shown 
in Fig.  1c, compared to non-induced E. coli, the IPTG-
induced cells had approximately 25  % less total cellular 
protein.
Maintenance and alteration of lipid asymmetry are 
deeply involved in the process of cell division. A number 
of phospholipid-modifying enzymes are responsible for 
generating asymmetry in the phospholipid composition 
of the inner and outer leaflets of cell membranes [20]. 
One such example is the constitutively expressed outer 
membrane phospholipase A1 found in E. coli and many 
other gram-negative bacteria [21]. It thus is reasonable to 
assume that high-level intracellular expression of foreign 
PLA1 can disturb the balanced asymmetry and deterio-
rate the integrity of the cell membrane. This assumption 
is also strengthened by the fact that exogenous PLA1s 
secreted from pathogenic bacteria, and those found in 
the venom of bees and snakes, cause destabilization and 
hemolysis of nearly all kinds of cells [22, 23].
Cell‑free synthesis of PLA1
Based on the assumption that E. coli-based expression of 
Serratia PLA1 is hampered by the membrane toxicity of 
the expressed enzyme, we decided to investigate the use 
of cell-free protein synthesis as an alternative expression 
platform for this enzyme. Because cell-free protein syn-
thesis reactions do not require the presence of an inte-
gral membrane, we expected that the enzymatic activity 
of the synthesized PLA1 would not inhibit continuous 
expression of this membrane-disrupting enzyme. For a 
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direct comparison, the same plasmid used for the E. coli-
based expression (pET21a Serr PLA1) was expressed in 
the cell-free synthesis reaction mixture under the condi-
tions described in “Methods” section. In contrast to the 
results from the cell-based expression, approximately 
0.35 mg/mL of Serratia PLA1 was produced after a 3 h 
incubation of the reaction mixture for cell-free synthesis. 
In addition, approximately 54 % of the synthesized pro-
tein was found in the soluble fraction. Figure  2a shows 
the results of quantitative measurements of the cell-free 
synthesized PLA1 along with the SDS-PAGE and immu-
noblot data. The relative advantage of using the cell-
free synthesis system is highlighted when the enzymatic 
activity of PLA1 was normalized to the amount of endog-
enous cellular proteins in the S12 extract. As presented in 
Fig. 2b, PLA1 activity per mg of endogenous protein was 
more than 1000 fold higher in the cell-free synthesis sys-
tem than when expressed in E. coli. Although PLA1 titer 
in E. coli significantly increased when the expression vec-
tor was switched from pET21a (T7 promoter) to pSTV28 
(lac promoter), still, normalized enzymatic activity of 
PLA1 was less than 0.4 % compared to the cell-free syn-
thesis system.
While we failed to obtain meaningful amounts of puri-
fied PLA1 from a 1 L culture of E. coli, a clear band of 
PLA1 was confirmed on the Coomassie blue-stained gel 
after purification from a 3 mL cell-free reaction (Fig. 3a). 
It was estimated that approximately 300  µg of purified 
PLA1 was recovered from the 3  mL cell-free synthesis 
reaction (recovery yield ≈40 %). The PLA1 enzyme puri-
fied from the 3  mL of cell-free synthesis reaction was 
used for degumming of crude sesame oil to test its usa-
bility in biodiesel production. As shown in Fig. 3b, incu-
bation with the cell-free synthesized PLA1 cleared the 
cloudy crude oil, indicating that the recombinant PLA1 
successfully catalyzed the degumming reaction. Gas 
chromatography analysis results also showed an increase 
in the concentration of linoleic acid in the oil depending 
on the amount of the used enzyme (Table  1 and Addi-
tional file 1: Figure S1).
We next examined whether the reaction volume of 
cell-free synthesis can be changed without affecting the 
productivity of functional enzymes. While optimal con-
ditions of heterogeneous cell culture often vary depend-
ing on size, the homogenous nature of cell-free protein 
synthesis reactions results in a more chemistry-like scale-
up [24, 25]. When the reaction volume of the cell-free 
PLA1 synthesis was sequentially increased from 150  µL 
to 500 mL, as shown in Fig. 4, the volumetric production 
of functional PLA1 was maintained consistently across 
the different reaction volumes examined (150 µL, 3 and 
500 mL).
Conclusions
PLA1 has broad applications in diverse industrial sectors 
[6, 26]. In this study, we demonstrated successful produc-
tion of Serratia sp. PLA1 in a cell-free protein synthesis 
system. Compared to E. coli-based expression, where the 
production of this enzyme was hampered by damage to 
cell growth and extremely low levels of expression, effi-
cient production of functional enzyme was achieved 
using cell-free protein synthesis. Furthermore, degum-
ming of crude oil was successfully performed by the 
PLA1 synthesized from our cell-free protein synthesis 
system. Including the PLA1 investigated in this study, 
many industrial enzymes can interfere with the regular 
physiology of cells, making their production problematic. 
With the experimental results presented herewith, we 
believe that cell-free protein synthesis can be considered 
as a versatile option for rapid production of important 
Fig. 1 Expression of recombinant PLA1 in E. coli. Escherichia coli strain BL21 (DE3) was grown in 400 mL of LB media after being transformed with 
the plasmid pET21a Serr PLA1. Samples of culture broth were taken throughout the culture period to measure optical density at 600 nm (a) and 
PLA1 activity (b) as described in the “Methods” section. At 16 h after induction with IPTG, the total amount of cellular protein was measured by the 
BCA assay (c). Arrows indicate the time point for IPTG induction. Results from the E. coli cultures with or without IPTG induction are shown in closed 
and open circles, respectively. Error bars represent the standard deviation from three independent experiments
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industrial biocatalysts. For now, the presented approach 
would be most ideal for high-speed screening and char-
acterization of enzymes because the high cost of the 
reagents can limit its scale-up for industrial production. 
With the present composition of the reaction mixture 
for cell-free synthesis, 1  mL of reaction mixture costs 
approximately 3.5 USD. As demonstrated in Additional 
file  2: Figure S2, energy source, extract preparation and 
nucleotide triphosphate account for more than 80  % of 
total reagent cost. Fortunately, it has been proven that the 
Fig. 2 Synthesis of PLA1 from Serratia sp. in a cell‑free protein synthesis system. The plasmid pET21a Serr PLA1 was incubated in the reaction mix‑
ture for cell‑free protein synthesis as described in “Methods” section. After incubation for 3 h, total and soluble amounts of cell‑free synthesized PLA1 
were quantified by measuring the TCA‑insoluble radioactivity of the samples (a). Embedded image of a shows the results of SDS‑PAGE and western 
blot analysis. PLA1 activity produced per mg of endogenous cellular protein in E. coli or cell‑free protein synthesis system was compared in b
Fig. 3 Purification of PLA1 expressed in each system. Cell‑free synthesized PLA1 from a 3 mL reaction was purified through a Ni‑NTA column (a). 
Turbidity of the crude sesame oil was cleared after incubation with the purified PLA1 (30 µg PLA1 in 10 mL oil) for 12 h at 40 °C, indicating that the 
cell‑free synthesized enzyme catalyzed degumming of crude oil (b)
Table 1 Gas chromatography analysis of crude sesame oil 
incubated with cell-free synthesized PLA1
10 mL of crude sesame oil was incubated with varying amounts of cell-free 









Page 6 of 7Lim et al. Biotechnol Biofuels  (2016) 9:159 
costs for these components can be markedly reduced by 
the use of cheap energy sources (glucose, for example), 
preparation of cell extract after high-cell density culture 
of E. coli cells and use of NMP instead of NTP, respec-
tively [27]. We thus expect that both the productivity and 
economics of cell-free synthesis of enzymes can be sub-
stantially improved for industrial applications in the near 
future.
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